PRPH ProPhase Labs, Inc.

Nasdaq prophaselabs.com


$ 0.51 $ -0.02 (-2.96 %)    

Wednesday, 15-Oct-2025 13:24:06 EDT
QQQ $ 599.69 $ -4.19 (-0.69 %)
DIA $ 462.00 $ -2.46 (-0.53 %)
SPY $ 662.49 $ -4.29 (-0.65 %)
TLT $ 90.61 $ -0.35 (-0.38 %)
GLD $ 385.67 $ -0.28 (-0.07 %)
$ 0.5256
$ 0.51
$ 0.51 x 1,500
$ 0.52 x 1,500
$ 0.51 - $ 0.54
$ 0.22 - $ 2.50
487,431
na
21.83M
$ 1.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-20-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-12-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-13-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 11-19-2020 09-30-2020 10-Q
21 08-11-2020 06-30-2020 10-Q
22 05-12-2020 03-31-2020 10-Q
23 03-26-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-12-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 03-26-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-20-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-28-2018 12-31-2017 10-K
32 11-13-2017 09-30-2017 10-Q
33 08-11-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 02-24-2017 12-31-2016 10-K
36 11-15-2016 09-30-2016 10-Q
37 08-11-2016 06-30-2016 10-Q
38 05-13-2016 03-31-2016 10-Q
39 03-29-2016 12-31-2015 10-K
40 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 prophase-labs-shareholders-approve-strategic-expansion-including-increase-in-authorized-shares-to-1b

ProPhase Labs Stockholders Deliver Strong Mandate at Special MeetingUNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase ...

 prophase-labs-q2-eps-011-beats-015-estimate-sales-1247m-may-not-be-comparable-to-3550m-estimate

The Company did not generate any revenues from diagnostic services for the three months ended June 30, 2025 and 2024, respectiv...

 prophase-labs-receives-nasdaq-extension-until-december-2025-to-regain-compliance-with-100-bid-price-requirement

ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consume...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION